Profile data is unavailable for this security.
About the company
Microport Scientific Corp Microport Scientific Corp is an investment holding company mainly engaged in the sale, manufacture, research and development (R&D) of medical devices. The Company operates in eight segments. The Cardiovascular Devices Business segment includes implantable devices and access devices. The Orthopedics Devices Business segment includes reconstructive joints and spine products. The Cardiac Rhythm Management (CRM) Business segment includes pacemakers and defibrillators. The Endovascular and Peripheral Vascular Devices Business segment includes L-REBOA aortic occlusion balloons. The Neurovascular Devices Business segment includes cerebral atherosclerotic stenosis and coil products. The Structural Heart Disease Business segment includes Transcatheter Aortic Valve Implantation. The Surgical Robot Business segment includes the manufacture and R&D of surgical robot devices. The Surgical Devices Business segment includes the manufacture and R&D of surgical devices.
- Revenue in HKD (TTM)7.97bn
- Net income in HKD-1.28bn
- Incorporated2006
- Employees6.29k
- LocationMicroport Scientific CorpNo. 1601 Zhangdong RoadZhangjiang Hi-Tech ParkSHANGHAI 201203ChinaCHN
- Phone+86 2 138954600
- Websitehttps://www.microport.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angelalign Technology Inc | 2.43bn | 184.75m | 12.83bn | 3.54k | 68.88 | 3.45 | 41.78 | 5.29 | 1.09 | 1.09 | 14.34 | 21.76 | 0.4195 | 6.80 | 8.48 | 679,033.10 | 2.99 | 4.48 | 4.10 | 5.73 | 62.52 | 63.83 | 7.13 | 11.67 | 2.69 | -- | 0.1587 | -- | 28.23 | 23.51 | 60.88 | 3.98 | 14.40 | -- |
| QingSong Health Corp | 1.41bn | 91.01m | 17.51bn | 205.00 | 192.41 | -- | 181.58 | 12.42 | 0.441 | 0.441 | 6.83 | -6.20 | -- | -- | -- | 7,228,269.00 | -- | -- | -- | -- | 32.06 | -- | 6.46 | -- | -- | -- | 3.27 | -- | 92.87 | -- | -90.75 | -- | -- | -- |
| MicroPort Scientific Corp | 7.97bn | -1.28bn | 21.65bn | 6.29k | -- | 4.29 | -- | 2.72 | -0.6968 | -0.6968 | 4.33 | 2.63 | 0.2694 | 1.23 | 3.24 | 1,255,801.00 | -5.23 | -11.96 | -9.45 | -19.14 | 54.13 | 59.67 | -19.43 | -48.95 | 1.15 | -1.63 | 0.5981 | -- | 8.45 | 5.38 | 55.19 | -- | -1.87 | -- |
| Shenzhen Edge Medical Co Ltd | 315.79m | -198.01m | 26.22bn | -- | -- | 19.36 | -- | 83.02 | -0.5107 | -0.5107 | 0.8145 | 3.46 | -- | -- | -- | -- | -- | -- | -- | -- | 61.90 | -- | -62.70 | -- | 10.86 | -- | 0.0114 | -- | 233.03 | -- | -2.65 | -- | -- | -- |
| Shanghai MicroPort MedBot Group Co Ltd | 377.52m | -541.44m | 29.60bn | 440.00 | -- | 48.89 | -- | 78.40 | -0.5504 | -0.5504 | 0.38 | 0.587 | 0.2545 | 1.11 | 7.18 | 838,932.90 | -36.76 | -42.31 | -62.94 | -52.87 | 33.18 | 28.11 | -144.46 | -936.40 | 1.45 | -26.62 | 0.5653 | -- | 145.95 | -- | 36.53 | -- | 62.90 | -- |
| Shanghai Conant Optical Co Ltd | 2.45bn | 557.08m | 32.22bn | 2.95k | 50.40 | 10.72 | 49.76 | 13.13 | 1.26 | 1.26 | 5.57 | 5.93 | 0.7988 | 2.46 | 5.61 | 900,980.10 | 18.14 | 14.77 | 23.71 | 20.63 | 39.52 | 36.69 | 22.71 | 16.80 | 2.79 | -- | 0.0845 | 19.94 | 17.11 | 14.25 | 30.96 | 30.79 | 31.32 | -- |
| Holder | Shares | % Held |
|---|---|---|
| HHLR Advisors Ltd.as of 23 Sep 2024 | 90.77m | 4.75% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 41.21m | 2.15% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 20.99m | 1.10% |
| Oasis Management Co. Ltd.as of 02 Jul 2024 | 18.11m | 0.95% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 13.35m | 0.70% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 10.04m | 0.53% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 7.82m | 0.41% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 7.25m | 0.38% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2025 | 6.06m | 0.32% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 5.78m | 0.30% |
